by Biolexis | Apr 13, 2023 | News & Media
April 14-19, 2023 Biolexis management participates and presents at the AACR (American Association of Cancer Research) Annual Meeting on April 14-19, 2023 – Orange County Convention Center, Orlando, Florida. AACR Annual Meeting...
by Biolexis | Apr 11, 2023 | News & Media
April 10-11, 2023 Biolexis Therapeutics CSO invited to present company MolecuLern™ technology at 2023 Annual San Antonio Drug Discovery Symposium held at Greehey Children’s Cancer Research Institute of University of Texas Health San Antonio....
by Biolexis | Apr 8, 2023 | News & Media
April 8-13, 2023 Biolexis management participated and presented pre-clinical data on CDK9 inhibitor at the AACR (American Association of Cancer Research) Annual Meeting on April 8-13, 2022, Ernest N. Morial Convention Center New Orleans, Louisiana. B137 / 13...
by Biolexis | Feb 23, 2023 | News & Media
February 22-23, 2023 Biolexis Therapeutics Business Development team participated 2nd Next Generation Kinase Inhibitors Summit was held on February 22-23, 2023, in Boston.
by Biolexis | Nov 14, 2022 | News & Media
November 14-15, 2022 Biolexis Therapeutics Management participates and presents their MolecuLern technology at Precision in Drug Discovery & Preclinical Summit 2022 on Nov 14-15, 2022, San Francisco CA, US.
by Biolexis | Oct 27, 2022 | News & Media
Oct 27-28, 2023 Biolexis Therapeutics Management participates and presents their MolecuLern technology at 10th Drug Discovery Strategic Summit, Oct 27th – 28th 2022, San Francisco CA, US